SAM® Junctional Tourniquet - SAM Medical

1 / 4

FDA

ISO

Free Shipping $200+ 30-Day Returns

Medical SME Veteran-Led

Secure HSA/FSA Gov/LE APO/FPO

Order Processing: Standard in-stock gear processes within 48 hours. Tracking is provided upon dispatch.

SKU: MEDTAC0657

Type: Tourniquet

Vendor: SAM Medical

SAM® Junctional Tourniquet

Name: SAM® Junctional Tourniquet
Brand: SAM Medical
SKU: MEDTAC0657
Price: 399.0 USD
Availability: InStock

MARCH PROTOCOL Built around MARCH. Evidence-based trauma care sequence →

Your Price: $399.00

FREE APO/FPO SHIPPING • EVERY ORDER • NO MINIMUM

Guaranteed duty-free priority delivery to all deployed military postal codes worldwide.

Ships from Florida HQ Free Shipping $200+ CONUS Free APO/FPO Shipping 30-Day Unopened Returns

$399.00

PRODUCT INFORMATION

SAM Medical · Junctional Tourniquet

SAM® Junctional Tourniquet

An FDA-cleared pneumatic junctional tourniquet for hemorrhage at the trunk–appendage junction — inguinal and axillary sites a circumferential limb tourniquet cannot reach — and for pelvic fracture stabilisation. Pneumatic Target Compression Devices are placed over the artery and inflated by hand pump; an AUTOSTOP buckle caps belt tension at 150 N. NSN 6515-01-618-7475.

Pneumatic TCDAUTOSTOP buckle · 150 NNSN 6515-01-618-7475510(k) cleared 2013

evidence-based removed the recommended designation from junctional tourniquets entirely in 2021 — no product in this category carries it, so device selection is a medical-director decision made on evidence, training burden and sustainment.

What's Included

SAM Medical publishes two pack configurations under this product — JT400-EN and JT401-EN — and they do not ship the same components. This listing carries a single variant and does not state which configuration is supplied. Both are itemised below; confirm the configuration before ordering.

VIEW ▾JT400-EN — two-TCD configuration — as published by SAM Medical

1× SAM® Junctional Tourniquet belt with AUTOSTOP Buckle — limits circumferential belt tension to 150 N
2× Target Compression Device (TCD) — repositionable, removable pneumatic compression pad; two TCDs allow simultaneous bilateral inguinal application
1× Belt extender
1× Hand pump
1× Auxiliary strap
The legacy listing itemises this configuration as '2 TCD + extender + pump + aux strap'. It does not state whether an instructions-for-use card is packed.

VIEW ▾JT401-EN — single-TCD configuration — as published by SAM Medical

1× SAM® Junctional Tourniquet belt with AUTOSTOP Buckle — limits circumferential belt tension to 150 N
1× Target Compression Device (TCD) — repositionable, removable pneumatic compression pad
1× Hand pump
No belt extender and no auxiliary strap are listed for this configuration. Bilateral inguinal application requires two TCDs and is therefore not supported by this pack as itemised.

▾Specifications

SAM® Junctional Tourniquet — specifications

Specification	Detail
Manufacturer	SAM Medical (Wilsonville, OR)
SKUs	JT400-EN — 2 TCD + extender + pump + auxiliary strap · JT401-EN — 1 TCD + pump
NSN	6515-01-618-7475
Mechanism	Pneumatic — hand-pump-inflated Target Compression Device (TCD) with AUTOSTOP Buckle
Belt tension limit	AUTOSTOP Buckle caps circumferential tension at 150 N, per SAM Medical
Inflation time	SAM Medical states the TCDs inflate in under 25 seconds by hand pump
Indications	SAM Medical states inguinal hemorrhage, axillary hemorrhage and pelvic fracture stabilisation
Maximum application time	SAM Medical states 4 hours (inguinal / axillary), with clinical monitoring per local protocol. The legacy listing does not cite the source document — verify against the current SAM Medical instructions for use before relying on this figure.
Platform origin	Developed from the SAM® Pelvic Sling platform
Weight	Approx. 2 lb, packaged configuration
Packaged dimensions	12″ H × 7.5″ W × 4.5″ D
FDA clearance	510(k) cleared 18 March 2013
Country of origin	Made in the USA
Clinical evaluation	Not evidence-based standard, and no junctional tourniquet is. TCCC Guidelines direct the use of a junctional tourniquet where the bleeding site is amenable to one, but in its 2021 update evidence-based removed the recommended designation from the junctional-tourniquet category entirely and directs end users to select any FDA-cleared device indicated for junctional hemorrhage control.
Preclinical evidence	A cadaveric study (Johnson et al., Journal of Special Operations Medicine, 2014) reported occlusion of the distal external iliac artery at a mean 107 mmHg versus 139 mmHg for manual compression, and 739 mmHg versus 1,237 mmHg at the axilla. A manikin comparison (Kragh et al., Prehospital and Disaster Medicine, 2016) reported the least blood loss of four tested junctional devices in groin scenarios. Both are preclinical models — read them as mechanism and usability evidence, not as a demonstrated survival benefit.
Fielding history	The U.S. Army Medical Materiel Agency fielded 460 units to theatre in October 2013 following FDA clearance.

Junctional hemorrhage — compressible bleeding at the groin, pelvis and axilla — is described in the Joint Trauma System literature as the largest remaining category of potentially survivable compressible hemorrhage after limb tourniquets were widely fielded. The common femoral artery exits the pelvis immediately below the inguinal ligament, too proximal for a limb-tourniquet cuff to engage.

▾Who Carries It

Combat medics, SOF medical providers and CASEVAC teams operating where blast mechanisms produce bilateral high-thigh wounds and proximal amputations · Tactical EMS and law-enforcement medics carrying a junctional capability alongside limb tourniquets · Role 1/2 and prolonged-field-care elements managing pelvic fracture as well as junctional bleeding · Trauma programmes and training centres standing up a junctional-hemorrhage capability.

A junctional tourniquet is a trained-provider device: Placement over the correct arterial landmark, inflation to the endpoint, monitoring during the application window and the decision to convert or remove all sit under training and medical-director protocol. Application technique and time limits belong to the manufacturer's instructions for use and your local protocol — not to a product page.

Genuine SAM Medical

Sourced direct from the manufacturer or an authorized master distributor. Ships from MED-TAC International, Pembroke Pines, FL — clinician-founded, veteran-led, SDVOSB-certified.

Built around MARCH. Every kit we sell maps to the MARCH protocol — Massive hemorrhage, Airway, Respiration, Circulation, Hypothermia. Learn the sequence in our complete MARCH guide.

SPECS & MEASUREMENTS

Specifications coming soon. Contact us for detailed product information.

SHIPPING & RETURNS

Domestic & Military Shipping

Free Standard Shipping: Automatically applied at checkout on all orders $200 and above within the 48 contiguous United States (CONUS).

APO/FPO Military Addresses: Unconditionally free standard shipping on every order, with no minimum purchase required.

Order Processing & Tracking

Standard Gear: In-stock medical devices, consumables, and tactical packs process within 48 hours.

Stocked Kit Bags: Custom-built kits ship within 7-10 days as they are assembled by hand at our South Florida facility.

Automated carrier tracking details are emailed immediately upon shipment dispatch.

30-Day Returns & Medical Safety

Returns: Unused, unopened equipment in original manufacturer packaging is eligible for return within 30 days of delivery.

Bio-Safety Notice: To ensure sterility and patient safety, medical consumables with opened or broken tamper-evident seals cannot be returned.

Return Facility: MED-TAC International Corp., 15757 Pines Blvd, Suite 154, Pembroke Pines, FL 33027.

Export Compliance

North American Rescue (NAR) products and rifle hard armor plates are strictly restricted to US and APO/FPO addresses and cannot be exported internationally.

FREQUENTLY ASKED QUESTIONS

Is the SAM Junctional Tourniquet CoTCCC-recommended?

Yes. The SAM® Junctional Tourniquet (SJT) is one of three CoTCCC-recommended junctional tourniquets, alongside the JETT and the Combat Ready Clamp. It was added to CoTCCC guidelines in 2013 following FDA 510(k) clearance on March 18, 2013 (NSN: 6515-01-618-7475). It is indicated for inguinal and axillary hemorrhage control and pelvic fracture stabilization and has been fielded by U.S. forces since October 2013. 'CoTCCC-recommended' means the Committee on Tactical Combat Casualty Care formally endorses its use in the TCCC guidelines.

How does the SAM Junctional Tourniquet stop bleeding where a regular tourniquet cannot?

The SAM JT uses pneumatic Target Compression Devices (TCDs) — inflatable pads attached to a circumferential pelvic belt — to deliver focused point pressure directly over the femoral artery below the inguinal ligament or over the axillary artery in the infraclavicular fossa. When inflated by hand pump, each TCD generates enough targeted pressure to occlude the underlying artery without the circumferential limb encirclement that standard windlass tourniquets require. In cadaveric testing, the SJT required only 107 mmHg of TCD pressure to occlude the external iliac artery at the inguinal ligament — significantly less than the 139 mmHg required by manual compression alone (Journal of Special Operations Medicine, 2014).

Can the SAM Junctional Tourniquet be used for bilateral injuries?

Yes. The full configuration (JT400-EN) includes two TCDs and one TCD extender, specifically enabling simultaneous bilateral inguinal deployment. In IED blast injuries involving bilateral high-thigh wounds or bilateral above-knee amputations — a frequent pattern in dismounted combat — both inguinal arteries can be occluded with a single belt application by positioning and inflating each TCD independently. This bilateral capability is a key clinical advantage over single-site junctional compression devices.

What is the AUTOSTOP Buckle and why does it matter?

The AUTOSTOP Buckle is the SJT's controlled-force mechanism, adapted from the SAM® Pelvic Sling. It limits circumferential belt tension to approximately 150N — the optimal threshold for both arterial occlusion and pelvic fracture reduction. An audible click confirms correct engagement. This prevents operator-dependent overtightening, which can vary widely under stress, fatigue, or training deficits, and ensures consistent occlusion force regardless of user experience level. The two prongs that activate at optimal force provide a tactile and auditory confirmation of proper application — a critical feature in high-stress environments.

How long can the SAM Junctional Tourniquet remain in place?

For inguinal and axillary applications, the manufacturer recommends a maximum application duration of 4 hours, consistent with guidance for other junctional devices. For abdominal/pelvic placement, shorter durations apply per clinical protocols. After 4 hours, ischemia-reperfusion risks increase. The casualty should be continuously monitored for hemorrhage recurrence, distal limb viability, and device stability — especially after transport, patient packaging, or transfer between care teams. Time of application must be documented immediately on the casualty's forehead and TCCC Casualty Card.